EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

The effect of propolis supplementation on cardiovascular risk factors in women with rheumatoid arthritis: A double‐blind, placebo, controlled randomized clinical trial

Mona Maddahi iD, Elyas Nattagh-Eshtivani iD, Mohammadhassan Jokar, Mehdi Barati iD, Hamed Tabesh iD, Mohammad Safarian iD, Maryam Khosravi iD

Phytotherapy Research · 2023

DOI: 10.1002/ptr.7996 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Phytotherapy Research, 2023. Verfasst von Mona Maddahi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Propolis, Cardiovascular Diseases, Arthritis, Rheumatoid. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 77 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Propolis has gained popularity in recent years because of its beneficial properties, which make it a possible preventative and therapeutic agent as well as a valuable food and cosmetic ingredient. The objective of this study was to evaluate the effects of propolis supplementation on cardiovascular risk factors in women with rheumatoid arthritis. This randomized, double‐blind, placebo‐controlled clinical trial was performed among 48 patients diagnosed with rheumatoid arthritis. Subjects were randomly assigned to placebo and intervention groups, supplemented with 1000 mg/day of propolis for 12 weeks. Cardiovascular risk factors including, high‐sensitivity C‐reactive protein (hs‐CRP), monocyte chemoattractant protein (MCP‐1), Nitric oxide, blood pressure, and lipid profile were assessed pre‐and post‐intervention. The atherogenic index of plasma value, as well as total cholesterol/high‐density lipoprotein cholesterol (HDL‐C), triglyceride/HDL‐C, and non‐HDL‐C/HDL‐C ratios, were significantly reduced in the intervention group, compared with the placebo group post‐intervention ( p < 0.05). Moreover, there was a significant reduction in the serum level of hs‐CRP in the intervention group when compared with the placebo group ( p = 0.001). Furthermore, propolis supplementation could marginally reduce MCP‐1 ( p = 0.051). These data indicate that propolis supplementation may be a promising treatment strategy for cardiovascular complications among rheumatoid arthritis patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropolisCardiovascular DiseasesArthritis, RheumatoidHumansFemaleC-Reactive ProteinRisk FactorsDietary SupplementsCholesterol, HDLHeart Disease Risk FactorsDouble-Blind Method

Stichwörter der Autor:innen

clinical trialinflammationpropolisrheumatoid arthritis

Substanzen

PropolisC-Reactive ProteinCholesterol, HDL

Autor:innen und Institutionen

  • Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Nutrition, Food Sciences and Clinical Biochemistry, School of Medicine, Social Determinants of Health Research Center, Gonabad University of Medical Science, Gonabad, Iran.
  • Rheumatic Diseases Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of pathobiology and laboratory sciences, North Khorasan University of Medical Sciences, Bojnurd, Iran.
  • Department of Medical Informatics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

ORCID-Profile: Mona Maddahi, Elyas Nattagh-Eshtivani, Mehdi Barati, Hamed Tabesh, Mohammad Safarian, Maryam Khosravi

Zitieren

APA

Maddahi, M., Nattagh-Eshtivani, E., Jokar, M., Barati, M., Tabesh, H., Safarian, M., & Khosravi, M. (2023). The effect of propolis supplementation on cardiovascular risk factors in women with rheumatoid arthritis: A double‐blind, placebo, controlled randomized clinical trial. Phytotherapy Research. https://doi.org/10.1002/ptr.7996

Vancouver

Maddahi M, Nattagh-Eshtivani E, Jokar M, Barati M, Tabesh H, Safarian M, et al. The effect of propolis supplementation on cardiovascular risk factors in women with rheumatoid arthritis: A double‐blind, placebo, controlled randomized clinical trial. Phytotherapy Research. 2023. doi:10.1002/ptr.7996

BibTeX
@article{Maddahi2023,
  author = {Maddahi, Mona and Nattagh-Eshtivani, Elyas and Jokar, Mohammadhassan and Barati, Mehdi and Tabesh, Hamed and Safarian, Mohammad and Khosravi, Maryam},
  title = {The effect of propolis supplementation on cardiovascular risk factors in women with rheumatoid arthritis: A double‐blind, placebo, controlled randomized clinical trial},
  journal = {Phytotherapy Research},
  year = {2023},
  doi = {10.1002/ptr.7996}
}
Kostenlos starten →